Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Olanzapine on Opioid Craving and Misuse in Cancer Pain
NCT06200181Phase 3Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in opioid use disorder (OUD), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2024; status: active, not recruiting.
02
Drugs
olanzapine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06200181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200181.